Kymera Therapeutics Files 8-K
Ticker: KYMR · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1815442
| Field | Detail |
|---|---|
| Company | Kymera Therapeutics, Inc. (KYMR) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financials
TL;DR
Kymera dropped an 8-K on 2/27 covering financials and exec changes.
AI Summary
Kymera Therapeutics, Inc. filed an 8-K on February 27, 2025, reporting on results of operations and financial condition, director/officer changes, and financial statements. The filing details information relevant to the company's ongoing operations and corporate governance.
Why It Matters
This 8-K filing provides updates on Kymera Therapeutics' financial health and any significant changes in its leadership or board composition, which are crucial for investors to assess the company's direction.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on standard corporate events and financial information, not indicating any immediate or unusual risks.
Key Players & Entities
- Kymera Therapeutics, Inc. (company) — Registrant
- February 27, 2025 (date) — Date of Report
- 001-39460 (other) — SEC File Number
- 81-2992166 (other) — IRS Employer Identification No.
- 500 North Beacon Street, 4th Floor, Watertown, Massachusetts 02472 (address) — Principal Executive Offices
- (857) 285-5300 (phone) — Business Phone
FAQ
What specific items are being reported in this 8-K filing by Kymera Therapeutics, Inc.?
This 8-K filing reports on Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, and Financial Statements and Exhibits.
On what date was this 8-K report filed by Kymera Therapeutics, Inc.?
The report was filed on February 27, 2025.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Kymera Therapeutics, Inc.
In which state was Kymera Therapeutics, Inc. incorporated?
Kymera Therapeutics, Inc. was incorporated in Delaware.
What is the business address of Kymera Therapeutics, Inc.?
The business address is 500 North Beacon Street, 4th Floor, Watertown, Massachusetts 02472.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Kymera Therapeutics, Inc. (KYMR).